Copyright: ©Author(s) 2026.
World J Exp Med. Mar 20, 2026; 16(1): 115508
Published online Mar 20, 2026. doi: 10.5493/wjem.v16.i1.115508
Published online Mar 20, 2026. doi: 10.5493/wjem.v16.i1.115508
Figure 1 Immunoexpression of caveolin-1 in ameloblastic fibroma, ameloblastic fibrodentinoma, ameloblastic fibro-odontoma, and odontoma.
A: Ameloblastic fibroma showing positivity (++) in ameloblastic epithelial islands and odontogenic mesenchymal cells; B: Ameloblastic fibrodentinoma with positivity (++) only in the ameloblastic epithelial component; C: Ameloblastic fibro-odontoma with positivity (++) in the ameloblastic epithelial component, also showing its relation to the formation of mineralized dental tissues (dentin); D: Odontoma with positivity (++) in the epithelial component. Immunohistochemistry, caveolin-1, A-D: × 20.
- Citation: Umpiérrez NG, Sicco E, Silveira F, Beovide AV, Bologna-Molina R. Differences of immunohistochemical profiling of MOC-31, caveolin-1, connexin-43, Ki-67 in ameloblastic fibroma, ameloblastic fibrodentinoma, ameloblastic fibro-odontoma, and odontomas. World J Exp Med 2026; 16(1): 115508
- URL: https://www.wjgnet.com/2220-315x/full/v16/i1/115508.htm
- DOI: https://dx.doi.org/10.5493/wjem.v16.i1.115508